General Range
NEBIPLE-2.5
Price on request/100 · MOQ 100 boxes
Nebiple-2.5 Tablets by Plena Remedies contain Nebivolol Hydrochloride, a selective beta-1 adrenergic blocker prescribed primarily for the management of hypertension (high blood pressure).
Nebivolol works by blocking beta-1 adrenergic receptors in the heart, helping reduce heart rate and cardiac workload. It also promotes nitric oxide-mediated relaxation of blood vessels, contributing to improved blood flow and lower blood pressure.
Nebiple-2.5 Tablets may be prescribed for adults requiring long-term blood pressure management. Maintaining controlled blood pressure helps reduce the risk of complications associated with hypertension, including stroke, heart disease and kidney damage.
The medicine should be taken strictly according to a registered medical practitioner's prescription. Dosage adjustments depend on blood pressure readings, heart rate, medical history and treatment response.
CategoryGeneral Range
Min. Order100 boxes
Supplied byPlena Remedies Pvt. Ltd.
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Nebivolol Hydrochloride Tablets IP
- Packaging Type
- Tablets
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Promotes nitric oxide-mediated vasodilation, contributing to lower blood pressure.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Plena Remedies Pvt. Ltd.Solan, Himachal Pradesh
Plena Remedies Pvt. Ltd. is an Indian pharmaceutical and healthcare company.
Key Details
• Incorporation / Establishment: Incorporated on August 22, 2023 (registered under corporate entities as Plena Remedies Private Limited in Himachal Pradesh), with brand origins dating back earlier.
• Registered Office / Location: Plot No. 17, Himuda Ind. Area, Bhatoli Kalan, Baddi, Solan, Himachal Pradesh, 173201, India.
• Leadership / Directors: Munesh Kumar (CEO / Director) and Vijay Singh.
• Certifications: ISO 9001:2015, WHO-GMP, and GLP certified.
• Core Business & Services:
• PCD Pharma Franchise: Offers monopoly-based franchise opportunities across India.
• Third-Party / Contract Manufacturing: Produces bulk formulations for other brands.
• Product Portfolio: 1,500+ certified formulations spanning tablets, capsules, injectables, syrups, dry syrups, ointments, and specialized divisions like pediatric, orthopedic, gynecology, dermatology, cardiology, and nutraceuticals.
• Ecosystem Partners: Associated with sister or collaborative entities like Itelic Labs and Rajora Biotech.
More General Range
